Upload
ali-mobasheri
View
232
Download
1
Tags:
Embed Size (px)
DESCRIPTION
THE COMPARATIVE CLINICAL SCIENCE FOUNDATION (CCSF)SECOND COLLABORATIVE WORKSHOP 16 MARCH 2011THE WELLCOME TRUST
Citation preview
THE COMPARATIVE CLINICAL SCIENCE FOUNDATION (CCSF)SECOND COLLABORATIVE WORKSHOP
16 MARCH 2011THE WELLCOME TRUST
Refining in vitro Models of Articular Cartilage Inflammation for Comparative Studies on Biomarkers of Osteoarthritis
Ali Mobasheri, D.Phil.
Musculoskeletal Research Group
School of Veterinary Medicine and Science
The Disease: Osteoarthritis (OA)
A progressive joint disease characterised by:– Articular cartilage
degeneration– Synovial inflammation– Subchondral bone sclerosis– Osteophyte formation (bony
outgrowths)
SynoviumSynovial fluid
Cartilage
Subchondral bone
The Disease: Osteoarthritis (OA)• Most common form of arthritis in humans and
animals • Major cause of pain, inflammation and loss of
mobility
Risk Factors for OA
• Age• Lifestyle and
occupation• Joint trauma or
instability• Genetics• Metabolic and
endocrine disease• Obesity
Normal Osteoarthritis
Weakened andfrayed tendons/ligaments, muscles
Episodically inflamedsynovium
Reduced viscosityof synovial fluid
Fibrillated/destroyedcartilage
Bony outgrowths(osteophytes)
Bone sclerosis
Frayed, cracked meniscus
Thickened capsule
Bone
Capsule
Synovial fluid
SynoviumMeniscus
Cartilage
Tendons/ligaments
Muscle
Rationale for Studying OA• OA affects 1 in 6 adults (almost 5 out of 6 professors in
the audience)• Most OA patients suffer from pain and disability• By 2030 20% of Americans and Europeans will have OA• There are no disease modifying treatments for OA• There are no established biomarkers for OA• Existing drugs (NSAIDs) only treat the symptoms of OA
– reducing pain and inflammation• Therefore OA represents a major opportunity for basic
and clinical research, drug discovery and the development of novel disease modifying agents and therapeutic approaches
Source: National Institute of Arthritis and Musculoskeletal and Skin Diseases,
NIAMS/National Institutes of Health, Bethesda, MD
Animal Models of OA
Procedures:Injection into the joint, surgical replication of joint trauma and creation of joint instability(cruciate transection, meniscal transection, carpal fragmentation)
Advantages:Equine and canine OA are good models of cartilage ageing, load-induced OA
Disadvantages:Ethical issues Invasive nature of techniquesAnaesthetics always requiredAnimals always sacrificedModels are expensive and laborious to
establishEndpoint data can be difficult to relate to
humans
Can we use explant and high-density culture models of
equine and canine cartilage to identify new biomarkers of OA that may identify early disease
and predict progression in humans and animals?
The Question:
Ideal for high-throughput screening, drug testing testing and studies on chondrocyte cell biology
In Vitro Models: Monolayer Cultures of Chondrocytes
Tissue is harvested under sterile conditions and pieces (explants) are placed in a cell culture dish containing growth media
• Advantages of the Cartilage Explant Culture Model: – Cells remain in their
original surrounding and the extracellular matrix around them accurately mimics the in vivo environment
– Ideal for studies of extracellular matrix synthesis and degradation
– Suitable for proteomic work and studying anti-inflammatory drugs and nutraceuticals
3-D Cartilage Explant Culture
Chondrocytes isolated by collagenase digestion
Cells counted and seeded into pre-gel mix and alginate beads set by addition of Ca2+
Beads cultured at 37oC, 5%
CO2
in DMEM + 10% FCS
Cells released by chelating Ca2+ with EDTA
Downstreamapplications
C
C
C
C
M
MA
A
M
M
A
Transmission electron micrograph of chondrocytes in alginate beads after 7 days of culture
In Vitro Models: 3-D Alginate Cultures of Chondrocytes
3-Dimensional High-Density Chondrocyte Pellet Culture Model
Petri Dish
CultureMedium Steel
Bridge
FilterChondrocytes + Growth Factors
Pellets Maintained at Air-Liquid Interface
P
P
M
P
C
C
C
C
M
M
M
TEM - Chondrocytes in High-Density Culture, after 7 days of culture
Current Research: Identifying and Validating New Biomarkers of Cartilage Degradation